Table 27:
Results of the Budget Impact Sensitivity Analysis
| Total Budget Impacta | ||||||
|---|---|---|---|---|---|---|
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Total | |
| Reference Case | ||||||
| Budget impact | −$103,541 | −$115,214 | −$134,474 | −$164,007 | −$208,306 | −$725,543 |
| Scenario 1: 10-kHz High-Frequency SCS With the Senza HF10b | ||||||
| Current scenario | $8,628,015 | $9,051,454 | $9,496,066 | $9,962,908 | $10,453,093 | $47,591,537 |
| Future scenario | $9,877,896 | $10,442,246 | $11,119,360 | $11,942,705 | $12,967,643 | $56,349,850 |
| Budget impact | $1,249,881 | $1,390,792 | $1,623,293 | $1,979,796 | $2,514,550 | $8,758,313 |
| Scenario 2: Larger Volume of Patients Eligible for 10-kHz High-Frequency SCS With the Freedom SCS Systemc | ||||||
| Current scenario | $57,402,364 | $60,273,141 | $63,287,458 | $66,452,490 | $69,775,774 | $317,191,228 |
| Future scenario | $56,624,159 | $59,415,798 | $62,299,534 | $65,264,344 | $68,287,294 | $311,891,129 |
| Budget impact | −$778,204 | −$857,344 | −$987,924 | −$1,188,147 | −$1,488,481 | −$5,300,099 |
| Scenario 3: Manufacturer Discountd | ||||||
| Current scenario | $7,374,085 | $7,743,422 | $8,131,227 | $8,538,421 | $8,965,975 | $40,753,130 |
| Future scenario | $7,274,671 | $7,632,801 | $8,002,112 | $8,380,951 | $8,765,972 | $40,056,507 |
| Budget impact | −$99,414 | −$110,621 | −$129,114 | −$157,470 | −$200,003 | −$696,622 |
| Scenario 4a: “No SCS Treatment” Current Scenario, Reference Case Target Populatione | ||||||
| Current scenario | $34,656 | $34,656 | $34,656 | $34,656 | $34,656 | $173,282 |
| Future scenario | $306,709 | $337,380 | $387,987 | $465,584 | $581,980 | $2,079,641 |
| Budget impact | $272,053 | $302,724 | $353,331 | $430,928 | $547,324 | $1,906,359 |
| Scenario 4b: “No SCS Treatment” Current Scenario, Larger Population Volumee | ||||||
| Current scenario | $34,656 | $34,656 | $34,656 | $34,656 | $34,656 | $173,282 |
| Future scenario | $2,079,383 | $2,287,322 | $2,630,420 | $3,156,504 | $3,945,630 | $14,099,260 |
| Budget impact | $2,044,727 | $2,252,665 | $2,595,764 | $3,121,848 | $3,910,974 | $13,925,978 |
| Scenario 5: Reduced Procedure Cost, Usual Care | ||||||
| Current scenario | $7,730,244 | $8,117,210 | $8,523,524 | $8,950,153 | $9,398,114 | $42,719,246 |
| Future scenario | $7,659,056 | $8,037,996 | $8,431,068 | $8,837,392 | $9,254,896 | $42,220,409 |
| Budget impact | −$71,188 | −$79,214 | −$92,456 | −$112,761 | −$143,218 | −$498,837 |
Note: Results may appear inexact due to rounding.
a
All costs are reported in 2018 Canadian dollars.
b
10-kHz high-frequency SCS with the Senza HF10 system outsourced via the Ontario Ministry of Health Out-of-Country Prior Approval program.
c
Larger volume of people eligible for 10-kHz high-frequency SCS with the Freedom SCS system.
d
A negotiated financial arrangement with the manufacturer.
e
A “do nothing” current scenario: 4a with reference case target volume and 4b with larger volume as estimated for scenario 2.